查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088592

混合成像市場：按技術類型、組件、系統類型、患者類型、應用和最終用戶分類－2026-2032年全球市場預測

Hybrid Imaging Market by Technology Type, Component, System Type, Patient Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，混合成像市場將成長至 137.2 億美元，複合年成長率為 6.90%。

主要市場統計數據
基準年 2025 86億美元
預計年份：2026年 91.9億美元
預測年份 2032 137.2億美元
複合年成長率 (%) 6.90%

融合核醫功能資訊與CT和MRI解剖詳細資訊的混合影像技術正逐漸成為精準診斷的臨床基礎。在許多已確立的適應症中，PET/CT、SPECT/CT和PET/MRI能夠幫助醫療團隊更可靠地定位病灶、量化生物活性、進行癌症分期、評估心肌活力、評估感染疾病和炎症，並輔助神經系統檢查，其可靠性遠超單一成像技術。

對於醫療服務提供者而言，混合影像技術的發展趨勢受到腫瘤領域檢查數量不斷增加、治療診斷學應用日益廣泛、放射性示踪劑和數位檢測器的可得性以及縮短診斷流程的壓力等因素的影響。最大的商業機會體現在掃描儀的效率、放射性藥物的取得、標準化的操作流程、輻射劑量管理以及整合放射科、核子醫學科、腫瘤科、循環系統和神經科等多學科報告的綜合服務模式等方面。

混合影像領域的變革性變化

混合成像領域的格局正在從以設備為中心的採購模式轉向端到端的診斷生態系統。醫療服務提供者不僅越來越重視掃描儀的規格，日益關注整體臨床處理能力、運轉率、劑量最佳化、放射性示蹤物流、影像重建速度、病患舒適度和報告互通性。

人工智慧對混合成像的累積影響

人工智慧 (AI) 透過加速影像重建、改進病灶檢測、實現運動校正、最佳化輻射計量以及標準化定量測量（例如標準化攝取值 (SUV)、代謝腫瘤體積 (MTV)、總病灶糖酵解 (TLG) 和心肌灌注參數），正在拓展混合成像的實際價值。在影像檢查量不斷成長以及放射學和核醫學領域人員短缺的背景下，AI 工具發揮著尤為重要的作用。

全球混合成像市場的關鍵區域洞察

北美憑藉其先進的腫瘤學網路、較高的PET/CT使用率、成熟的保險報銷體系、學術研究中心以及完善的放射性藥物供應鏈，仍然是混合影像領域的領先地區。歐洲受益於統一的臨床指南、核醫專業知識和健全的公共衛生體系，同時，歐盟的癌症控制舉措、跨境研究和放射學品質管理計畫正在推動PET/CT、SPECT/CT和PET/MRI等技術在實證醫學基礎上的應用。

針對不同族群採用混合成像技術的關鍵見解

東協地區的需求主要受私人醫療保健、醫療旅遊、國家癌症控制計劃以及政府在癌症診斷領域投資的推動，儘管放射性藥物、迴旋加速器和訓練有素的核子醫學專家的供應情況因國家而異。海灣合作理事會（GCC）市場正透過醫療保健轉型、專科癌症中心和公私合營醫院的擴張以及對支持PET/CT和其他混合成像平台的先進診斷基礎設施的投資而蓬勃發展。

主要國家混合成像需求分析

美國在PET/CT應用、腫瘤影像、人工智慧驅動的工作流程、放射性藥物創新以及治療診斷學照護路徑方面處於主導。而加拿大則更注重集中式照護路徑、省級醫保報銷體係以及地域分散的人口享有公平的醫療服務。在墨西哥和巴西，混合影像技術正透過私立醫院網路、三級醫療機構和腫瘤中心推廣，但由於設備集中度、放射性示蹤劑物流和專科醫生資源等因素，大都會圈仍然難以獲得此類服務。

為醫療保健機構領導者提供的實用建議

醫療機構領導者應優先投資混合影像技術，以提高臨床診療能力、診斷準確性和診療路徑整合度。最具影響力的措施包括：根據疾病轉診量選擇掃描儀；確保放射性示踪劑供應充足；開發跨學科解讀模型；制定腫瘤科、循環系統、神經科和感染疾病影像的標準化方案；以及根據公認的安全原則追蹤輻射暴露情況。

混合成像市場分析的調查方法

本執行摘要基於二手研究、資訊來源檢驗以及專家對檢驗的公共領域和行業資訊來源的解讀。輸入資料包括臨床指南、監管資料庫、放射學和核子醫學文獻、醫院採購趨勢、報銷框架、公共衛生統計資料、放射性藥物取得指標以及醫療基礎設施基準。

結論：混合影像作為精準醫療平台

混合成像正從一項專門的診斷服務轉變為精準醫療的策略支柱。醫療機構若能將先進的PET/CT、SPECT/CT和PET/MRI平台與可靠的放射性示蹤劑、人工智慧驅動的工作流程、輻射安全措施以及多學科報告相結合，將更有利於改善治療效果並滿足日益成長的診斷需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 混合成像市場：依技術類型分類

  • PET-CT
  • PET-MRI
  • Spect-CT

第8章 混合影像市場：依組件分類

  • 硬體
    • 影像系統
    • 檢測器
    • 掃描器
  • 軟體
    • 影像分析軟體
    • 工作流程最佳化工具
  • 服務

第9章 混合成像市場：依系統類型分類

  • 獨立系統
  • 整合系統

第10章 混合影像市場：依病患類型分類

  • 兒童
  • 成人
  • 老年人

第11章：混合影像市場：按應用領域分類

  • 循環系統
    • 心肌灌注
    • 存活率
  • 感染疾病
    • 感染部位影像
    • 發炎成像
  • 神經病學
    • 癲癇
    • 神經退化性疾病
  • 腫瘤學
    • 骨髓惡性腫瘤
    • 固體癌

第12章 混合成像市場：依最終用戶分類

  • 診斷中心
  • 醫院
  • 研究機構

第13章：混合影像市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 混合影像市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 混合影像市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Agfa-Gevaert NV
  • Bracco Imaging SpA
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Carl Zeiss Meditec AG
  • CMR Naviscan Corporation
  • Cubresa Inc.
  • Curium US LLC
  • Digirad Corporation
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Heidelberg Engineering GmbH
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Mediso Medical Imaging Systems Ltd.
  • MILabs BV
  • Mirion Technologies, Inc.
  • MR Solutions Ltd.
  • Neusoft Medical Systems Co., Ltd.
  • PerkinElmer, Inc.
  • Planmed Oy
  • Samsung Medison Co., Ltd.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Spectrum Dynamics Medical Ltd.
  • Topcon Corporation
  • TriFoil Imaging, Inc.
Product Code: MRR-0360AB17DFF6

The Hybrid Imaging Market is projected to grow by USD 13.72 billion at a CAGR of 6.90% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.60 billion
Estimated Year [2026] USD 9.19 billion
Forecast Year [2032] USD 13.72 billion
CAGR (%) 6.90%

Hybrid imaging has become a clinical cornerstone for precision diagnosis because it fuses functional information from nuclear medicine with anatomic detail from CT or MRI. PET/CT, SPECT/CT, and PET/MRI help care teams localize disease, quantify biologic activity, stage cancer, evaluate cardiac viability, assess infection and inflammation, and support neurologic workups with higher confidence than standalone modalities in many established indications.

For healthcare providers, the hybrid imaging landscape is being shaped by rising oncology volumes, broader use of theranostics, improved radiotracer availability, digital detector technology, and pressure to shorten diagnostic pathways. The strongest opportunities are linked to integrated service models that combine scanner productivity, radiopharmacy access, standardized protocols, radiation dose management, and multidisciplinary reporting across radiology, nuclear medicine, oncology, cardiology, and neurology.

Transformative Shifts in the Hybrid Imaging Landscape

The hybrid imaging landscape is shifting from equipment-centered purchasing to end-to-end diagnostic ecosystems. Providers are increasingly evaluating total clinical throughput, uptime, dose optimization, radiotracer logistics, image reconstruction speed, patient comfort, and reporting interoperability rather than scanner specifications alone.

A second transformation is the move from episodic imaging to longitudinal decision support. Hybrid imaging is now embedded in cancer staging, therapy response assessment, cardiac risk stratification, and treatment planning. Digital PET, solid-state SPECT, low-dose CT protocols, and PET/MRI workflow improvements are enabling more precise imaging while supporting patient-centered care, value-based reimbursement, and multidisciplinary tumor board decision-making.

Cumulative Impact of Artificial Intelligence on Hybrid Imaging

Artificial intelligence is expanding the practical value of hybrid imaging by accelerating image reconstruction, improving lesion detection support, enabling motion correction, optimizing dose, and standardizing quantitative measurements such as standardized uptake value, metabolic tumor volume, total lesion glycolysis, and myocardial perfusion parameters. AI-enabled tools are particularly relevant where rising imaging volumes meet workforce shortages in radiology and nuclear medicine.

For providers, the cumulative impact is operational as much as clinical. AI can help reduce repeat scans, streamline protocol selection, prioritize urgent cases, support structured reporting, and improve consistency in follow-up comparisons. Adoption should remain governed by clinical validation, bias testing, cybersecurity controls, regulatory compliance, and clinician oversight because hybrid imaging decisions directly influence cancer therapy, cardiac intervention, neurologic assessment, and advanced treatment pathways.

Key Regional Insights Across Global Hybrid Imaging Markets

North America remains a leading hybrid imaging region due to advanced oncology networks, high PET/CT utilization, mature reimbursement pathways, academic research centers, and established radiopharmaceutical supply chains. Europe benefits from coordinated clinical guidelines, nuclear medicine expertise, and strong public health systems, while European Union cancer initiatives, cross-border research, and radiology quality programs support evidence-based adoption of PET/CT, SPECT/CT, and PET/MRI.

Asia-Pacific is expanding as China, Japan, India, South Korea, and Australia invest in cancer diagnostics, private hospital capacity, cyclotron networks, radiopharmaceutical access, and high-end imaging infrastructure. Latin America shows selective advancement led by Brazil and Mexico, where tertiary hospitals and private diagnostic groups are upgrading PET/CT access for oncology and cardiology use. The Middle East is progressing through specialty hospitals, oncology centers, and GCC healthcare modernization programs, while Africa remains uneven, with adoption concentrated in major urban centers where radiotracer access, trained nuclear medicine professionals, service maintenance, and capital financing are available.

Key Group Insights for Hybrid Imaging Adoption

ASEAN demand is supported by expanding private healthcare, medical tourism, national cancer programs, and government investment in oncology diagnostics, although radiopharmaceutical distribution, cyclotron availability, and trained nuclear medicine staffing vary by country. GCC markets are strengthening through healthcare transformation agendas, specialty oncology centers, public-private hospital expansion, and investment in advanced diagnostic infrastructure that supports PET/CT and other hybrid imaging platforms.

The European Union offers a favorable environment for protocol standardization, multicenter research, radiopharmaceutical regulation, and responsible AI adoption in imaging workflows. BRICS countries create scale opportunities because of large patient populations, rising cancer and cardiovascular disease burden, and expanding hospital infrastructure, but procurement models, reimbursement coverage, and access outside major cities differ widely. G7 markets lead in clinical evidence generation, reimbursement maturity, quality assurance, and installed-base replacement, while NATO member countries increasingly emphasize resilient medical supply chains, cybersecurity, radiopharmaceutical continuity, and protection of critical imaging services during system disruptions.

Key Country Insights in Hybrid Imaging Demand

The United States leads in PET/CT utilization, oncology imaging, AI-enabled workflow adoption, radiopharmaceutical innovation, and theranostic care pathways, while Canada emphasizes centralized care pathways, provincial reimbursement structures, and equitable access across geographically dispersed populations. Mexico and Brazil are expanding hybrid imaging through private hospital networks, tertiary care institutions, and oncology centers, although access outside large metropolitan areas remains constrained by equipment concentration, radiotracer logistics, and specialist availability.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong demand through national cancer strategies, academic medicine, public health coverage, and established nuclear medicine capacity, while Russia retains hybrid imaging capabilities in major metropolitan centers despite procurement and supply-chain complexity. China is scaling high-end imaging, domestic equipment capabilities, and hospital-based nuclear medicine services; India is adding PET/CT capacity alongside oncology hospital growth and expanding private diagnostics; Japan and South Korea are advanced markets for precision diagnostics, digital imaging workflows, and specialized clinical protocols; and Australia benefits from strong specialist networks, public-private diagnostic infrastructure, and established nuclear medicine practice.

Actionable Recommendations for Healthcare Provider Leaders

Provider leaders should prioritize hybrid imaging investments that improve clinical throughput, diagnostic confidence, and care pathway integration. The highest-impact actions include aligning scanner selection with disease-specific referral volumes, securing radiotracer supply redundancy, building cross-specialty reading models, standardizing protocols for oncology, cardiology, neurology, and infection imaging, and tracking radiation dose in line with recognized safety principles.

Executives should also create AI governance frameworks before deployment, including validation against local patient populations, performance monitoring, data privacy safeguards, cybersecurity testing, user training, and clear escalation rules for discordant findings. Partnerships with radiopharmacies, academic centers, referring physicians, service providers, and technology vendors can improve utilization while supporting measurable outcomes such as report turnaround time, scan repeat rates, patient wait times, protocol adherence, and therapy planning efficiency.

Research Methodology for Hybrid Imaging Market Analysis

This executive summary is developed through secondary research, source triangulation, and expert interpretation of validated public-domain and industry sources. Inputs include clinical guidelines, regulatory databases, radiology and nuclear medicine literature, hospital procurement trends, reimbursement frameworks, public health statistics, radiopharmaceutical access indicators, and healthcare infrastructure benchmarks.

The analysis emphasizes evidence consistency across sources rather than speculative projections. Regional, group, and country insights are assessed through installed-base maturity, disease burden relevance, radiopharmaceutical access, reimbursement readiness, workforce availability, technology adoption, regulatory environment, AI governance readiness, and healthcare investment patterns.

Conclusion: Hybrid Imaging as a Precision Medicine Platform

Hybrid imaging is moving from a specialized diagnostic service to a strategic pillar of precision medicine. Providers that combine advanced PET/CT, SPECT/CT, and PET/MRI platforms with reliable radiotracer access, AI-enabled workflow, radiation safety practices, and multidisciplinary reporting will be better positioned to improve outcomes and manage rising diagnostic demand.

The next phase of market advantage will depend on integration rather than equipment alone. Organizations that align clinical evidence, operational excellence, reimbursement readiness, workforce development, supply-chain resilience, and digital governance can convert hybrid imaging into a scalable engine for earlier diagnosis, better treatment planning, and more efficient care delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Hybrid Imaging Market, by Technology Type

  • 7.1. Pet-CT
  • 7.2. Pet-MRI
  • 7.3. Spect-CT

8. Hybrid Imaging Market, by Component

  • 8.1. Hardware
    • 8.1.1. Imaging Systems
    • 8.1.2. Detectors
    • 8.1.3. Scanners
  • 8.2. Software
    • 8.2.1. Imaging Analysis Software
    • 8.2.2. Workflow Optimization Tools
  • 8.3. Services

9. Hybrid Imaging Market, by System Type

  • 9.1. Standalone Systems
  • 9.2. Integrated Systems

10. Hybrid Imaging Market, by Patient Type

  • 10.1. Pediatric
  • 10.2. Adult
  • 10.3. Geriatric

11. Hybrid Imaging Market, by Application

  • 11.1. Cardiology
    • 11.1.1. Myocardial Perfusion
    • 11.1.2. Viability
  • 11.2. Infectious Diseases
    • 11.2.1. Infection Site Imaging
    • 11.2.2. Inflammation Imaging
  • 11.3. Neurology
    • 11.3.1. Epilepsy
    • 11.3.2. Neurodegenerative
  • 11.4. Oncology
    • 11.4.1. Hematologic Malignancies
    • 11.4.2. Solid Tumors

12. Hybrid Imaging Market, by End User

  • 12.1. Diagnostic Centers
  • 12.2. Hospitals
  • 12.3. Research Institutes

13. Hybrid Imaging Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Hybrid Imaging Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Hybrid Imaging Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Agfa-Gevaert N.V.
  • 17.2. Bracco Imaging S.p.A.
  • 17.3. Bruker Corporation
  • 17.4. Canon Medical Systems Corporation
  • 17.5. Carestream Health, Inc.
  • 17.6. Carl Zeiss Meditec AG
  • 17.7. CMR Naviscan Corporation
  • 17.8. Cubresa Inc.
  • 17.9. Curium US LLC
  • 17.10. Digirad Corporation
  • 17.11. Esaote S.p.A.
  • 17.12. Fujifilm Holdings Corporation
  • 17.13. GE HealthCare Technologies Inc.
  • 17.14. Heidelberg Engineering GmbH
  • 17.15. Hologic, Inc.
  • 17.16. Koninklijke Philips N.V.
  • 17.17. Mediso Medical Imaging Systems Ltd.
  • 17.18. MILabs B.V.
  • 17.19. Mirion Technologies, Inc.
  • 17.20. MR Solutions Ltd.
  • 17.21. Neusoft Medical Systems Co., Ltd.
  • 17.22. PerkinElmer, Inc.
  • 17.23. Planmed Oy
  • 17.24. Samsung Medison Co., Ltd.
  • 17.25. Shanghai United Imaging Healthcare Co., Ltd.
  • 17.26. Shimadzu Corporation
  • 17.27. Siemens Healthineers AG
  • 17.28. Spectrum Dynamics Medical Ltd.
  • 17.29. Topcon Corporation
  • 17.30. TriFoil Imaging, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HYBRID IMAGING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL HYBRID IMAGING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL HYBRID IMAGING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL HYBRID IMAGING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL HYBRID IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL HYBRID IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL HYBRID IMAGING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL HYBRID IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL HYBRID IMAGING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL HYBRID IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL HYBRID IMAGING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL HYBRID IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PET-CT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PET-CT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PET-CT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PET-MRI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PET-MRI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PET-MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SPECT-CT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SPECT-CT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SPECT-CT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DETECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DETECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DETECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SCANNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SCANNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IMAGING ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IMAGING ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL IMAGING ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL WORKFLOW OPTIMIZATION TOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL WORKFLOW OPTIMIZATION TOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL WORKFLOW OPTIMIZATION TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL STANDALONE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL STANDALONE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL STANDALONE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTEGRATED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTEGRATED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTEGRATED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MYOCARDIAL PERFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MYOCARDIAL PERFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MYOCARDIAL PERFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VIABILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VIABILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VIABILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INFECTION SITE IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INFECTION SITE IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INFECTION SITE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INFLAMMATION IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INFLAMMATION IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INFLAMMATION IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEURODEGENERATIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEURODEGENERATIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEURODEGENERATIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SOLID TUMORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SOLID TUMORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SOLID TUMORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HYBRID IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL HYBRID IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. GCC HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. GCC HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 197. GCC HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 198. GCC HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. GCC HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. GCC HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. GCC HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. GCC HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 204. GCC HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. GCC HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. GCC HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. G7 HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. G7 HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. G7 HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 236. G7 HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 237. G7 HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. G7 HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. G7 HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. G7 HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 243. G7 HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. G7 HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. G7 HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. NATO HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. NATO HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 249. NATO HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 251. NATO HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. NATO HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. NATO HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. NATO HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. NATO HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 256. NATO HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. NATO HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. GLOBAL HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. CANADA HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. CANADA HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. CANADA HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 276. CANADA HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 277. CANADA HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 278. CANADA HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. CANADA HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. CANADA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 281. CANADA HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 282. CANADA HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 283. CANADA HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 285. CANADA HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. MEXICO HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. MEXICO HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. MEXICO HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 289. MEXICO HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 290. MEXICO HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 291. MEXICO HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. MEXICO HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. MEXICO HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. MEXICO HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. MEXICO HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 296. MEXICO HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 297. MEXICO HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. MEXICO HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. BRAZIL HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. BRAZIL HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. BRAZIL HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 302. BRAZIL HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 303. BRAZIL HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 304. BRAZIL HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. BRAZIL HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. BRAZIL HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. BRAZIL HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 308. BRAZIL HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 309. BRAZIL HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 310. BRAZIL HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 311. BRAZIL HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 325. GERMANY HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 326. GERMANY HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. GERMANY HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 328. GERMANY HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 329. GERMANY HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 330. GERMANY HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. GERMANY HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. GERMANY HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 333. GERMANY HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 334. GERMANY HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 335. GERMANY HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 336. GERMANY HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 337. GERMANY HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 338. FRANCE HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 339. FRANCE HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 340. FRANCE HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 341. FRANCE HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 342. FRANCE HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 343. FRANCE HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 344. FRANCE HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 345. FRANCE HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 346. FRANCE HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 347. FRANCE HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 348. FRANCE HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 349. FRANCE HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 350. FRANCE HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 351. RUSSIA HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 352. RUSSIA HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 353. RUSSIA HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 354. RUSSIA HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 355. RUSSIA HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 356. RUSSIA HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 357. RUSSIA HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 358. RUSSIA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 359. RUSSIA HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 360. RUSSIA HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 361. RUSSIA HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 362. RUSSIA HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 363. RUSSIA HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 364. ITALY HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 365. ITALY HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 366. ITALY HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 367. ITALY HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 368. ITALY HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 369. ITALY HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 370. ITALY HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 371. ITALY HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 372. ITALY HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 373. ITALY HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 374. ITALY HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 375. ITALY HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 376. ITALY HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 377. SPAIN HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 378. SPAIN HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 379. SPAIN HYBRID IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 380. SPAIN HYBRID IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 381. SPAIN HYBRID IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 382. SPAIN HYBRID IMAGING MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 383. SPAIN HYBRID IMAGING MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 384. SPAIN HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 385. SPAIN HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 386. SPAIN HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 387. SPAIN HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 388. SPAIN HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 389. SPAIN HYBRID IMAGING MAR